In this guide
A search for tirzepatide storage can turn up several different temperatures and time limits. Before choosing one, identify the exact medicine you have. A Zepbound pen, a Mounjaro vial and a compounded preparation should not be treated as one storage product simply because they are associated with tirzepatide.
Use the instructions for your exact product and presentation, keep track of the applicable dates, and resolve uncertain storage conditions before using the medicine. For compounded multidose GLP-1 vials, FDA also gives an explicit first-use discard recommendation; a longer pharmacy instruction should not be treated as permission to ignore it. 1
The questions below help you separate those instructions and dates.
Start with the product in your hands
Read the product label and keep its written directions with the medicine. Identify the product and supplied form. If the label says compounded tirzepatide, use the directions for that preparation rather than a brand’s instructions as a substitute.
For branded products only: Zepbound and Mounjaro have their own US prescribing information, with separate storage instructions for single-dose presentations, multi-dose vials and single-patient-use KwikPens. 4, 5 Use the instructions matching the actual presentation supplied. A rule from another device, formulation or country may not apply.
If storage directions are missing, unclear or conflict with one another, ask a pharmacist to explain them before use. Written clarification gives you a clear reference for later handling questions.
Does tirzepatide expire?
Yes—medicines have limits on how long they should be kept and used. The useful question is which limit applies to your particular product and its storage history.
FDA explains that an expiration date reflects the period a medicine is known to maintain its strength, quality and purity when stored under its labeled conditions. 2 A date on the package does not cancel a storage problem or a shorter limit that applies after first use.
You may encounter three different kinds of dating:
| Date or limit | What it means | What to clarify |
|---|---|---|
| Manufacturer expiration date | The dated shelf-life limit for the manufactured product under its labeled storage conditions. | Where it appears on the package and which storage conditions apply. |
| Pharmacy beyond-use date, often called BUD | A date beyond which the dispensed preparation should not be used. | The printed date and the storage conditions attached to it. |
| First-use or opening limit | A separate limit that begins with the event specified in the applicable directions. | What counts as first use or opening, when it occurred and the resulting discard deadline. |
FDA’s expiration guidance supports the first distinction; its pharmacy terminology explains BUD. Product labeling and the FDA compounded-vial guidance address first-use limits. 1, 2, 3
Ask the pharmacist to identify each applicable limit rather than assuming that one date replaces the others. A later printed BUD does not erase an earlier first-use discard deadline. A first-use period also does not extend an earlier BUD. FDA advises against using expired medicines. 6
What changes after first use of a compounded multidose vial?
In its guidance on compounded GLP-1 drugs, FDA generally recommends that vials containing multiple doses of sterile medicine be used within 28 days after first use because contamination risk increases afterward. It tells consumers to discard the vial within 28 days of first use, even if medicine remains and even if the compounder gives instructions allowing longer use. 1
This is FDA’s general recommendation in that compounded-multidose-vial context. It is not a universal unopened shelf life, a promise that every vial remains suitable for all 28 days, or a replacement for an earlier BUD or shorter applicable discard instruction. It should not be substituted for an FDA-approved brand’s presentation-specific labeling.
Keep a record of the first-use date. Ask the pharmacist to confirm how it relates to the printed BUD and any shorter instructions for your preparation. If you cannot establish when the vial was first used, do not guess a new date to extend its use; contact the pharmacist before using it again.
What if a shipment arrives warm?
FDA recommends not using an injectable GLP-1 medicine that arrives warm or with insufficient refrigeration, because its quality can be affected. 1
Contact a pharmacist or your prescribing clinician about next steps. Have the product label and any available information about its delivery conditions ready. Describe what you observed without guessing a temperature you did not measure.
A future expiration date or a normal-looking solution should not be used to overrule that shipping concern. Appearance is not a substitute for the applicable handling requirements.
What if it was left out, overheated or possibly frozen?
A temperature excursion means the medicine may have been outside its specified storage conditions. How that affects a particular product cannot be decided from the ingredient name alone. FDA notes that inappropriate storage can affect medicines even before their printed expiration date. 6
Do not use the medicine while its suitability is unresolved. Contact a pharmacist or your prescribing clinician for product-specific advice. Explain what happened, for how long, the temperatures you actually know and any uncertainty. If freezing is possible, say so explicitly.
Do not borrow another product’s allowance or treat placing the medicine back into its usual storage location as permission to use it. A pharmacist needs the actual product and the circumstances, not just the word “tirzepatide.”
How can you prepare for everyday storage and travel?
For everyday handling and travel, review these points in your written instructions:
- The required storage conditions for your exact preparation and container.
- Any different instructions before and after first use.
- The BUD and applicable discard deadline, including the FDA compounded-multidose-vial recommendation.
- How to maintain the specified conditions during your planned journey.
- Whom to contact after a shipment problem, power interruption or uncertain exposure.
- How to dispose of medicine and used supplies appropriately.
Keep the label and directions accessible so you can identify the product when asking for help. Ask a pharmacist about travel conditions before leaving; a cooling pouch or ice pack should not be assumed to meet your medicine’s requirements.
If a date has passed or storage is uncertain, ask about safe disposal and replacement. Do not try to make the remaining supply last by using it beyond the applicable limit. Clear dates, the correct instructions and an identified contact are the most useful tools for handling a storage question.
Sources
- FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, especially the compounded multidose-vial and shipping sections. Checked October 12, 2026.
- Expiration Dates — Questions and Answers, FDA. Checked October 12, 2026.
- Questions and Answers on Current Good Manufacturing Practice Requirements: Laboratory Controls, FDA. Question 6’s parenthetical BUD definition only; its discussion of repackaged oral medicines does not supply a storage duration for compounded tirzepatide. Checked October 12, 2026.
- Zepbound US prescribing information, Eli Lilly and Company. Revised August 2026, section 16.2. Branded-product reference only; checked October 12, 2026.
- Mounjaro US prescribing information, Eli Lilly and Company. Revised August 2026, section 16.2. Branded-product reference only; checked October 12, 2026.
- Don’t Be Tempted to Use Expired Medicines, FDA. Checked October 12, 2026.